EntryPoint Capital’s Amgen AMGN Stock Holding History

EntryPoint Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,086	Closed	-$804K	–	664
2024 Q4	$804K	Buy	+3,086	New	+$916K	0.34%	11
2024 Q2	–	Sell	-119	Closed	-$33.8K	–	866
2024 Q1	$33.8K	Sell	119 -59	-33%	-$17.3K	0.03%	920
2023 Q4	$51.3K	Buy	+178	New	+$48.5K	0.05%	704

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EntryPoint Capital's AMGN Position: Q1 2025 in Review

EntryPoint Capital sold out of Amgen (AMGN) in Q1 2025, closing a stake of 3,086 shares — an estimated $804K sold.

EntryPoint Capital first reported a position in AMGN in Q4 2023 and held it in 3 quarters. The position peaked at $804K in Q4 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

EntryPoint Capital reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
EntryPoint Capital sold 3,086 Amgen shares in Q1 2025, an estimated $804K.
EntryPoint Capital first reported a position in Amgen in Q4 2023 and held it in 3 quarters.
EntryPoint Capital's Amgen position peaked at $804K in Q4 2024.
2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.